Partner Luigi Negri’s new book “De-Risking Investments in Medical Technology Innovation” is out with Springer.

“De‑Risking Investments in Medical Technology Innovation” is now out with Springer!

The book is written by our partner Luigi Negri, with Nicola Redi adding the investor’s view on leadership, valuation and decision‑making under uncertainty.

While the application focus is MedTech, the underlying methodology is relevant to any STEM innovation. It’s about turning scientific rigor into business rigor:
→ breaking a venture into a finite set of assumptions
→ deciding which risk to reduce first when resources are scarce
→ keeping a “grip on reality” as data, stakeholders and markets keep shifting.

For Obloo Ventures, this is the written version of the approach we apply every day with startups in space, robotics, computational sciences and energy.

If you’re working on a STEM venture and want a structured way to think about risk, this is a resource we are proud to stand behind - as authors, as investors and as practitioners.

Discover it on Springer - 20% off with code SPRAUT: https://lnkd.in/dwgw3vjR